The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

the use of paracetamol as a first-line pain killer for long-term conditions such as osteoarthritis in older people needs to be carefully considered.” It comes as the Therapeutic Goods ...

A SINGLE mum's suspected diabetes symptoms turned out to be incurable cancer. Jodie Hill, 46, was told she had three months to live just before her son Alfie's 13th birthday. It all started when ...

“This has killed our entire family. This has brought so much pain and so much hurt for our entire family,” Dzeneta Husic, Sejdinovic’s cousin, said at the lobby of the Regional Justice Center. Family ...

in 2019, where he worked as an anesthesiologist and pain management specialist at Madigan Army Medical Center. He was suspended from patient care duties in 2022 following several allegations of ...

Directed by Adolfo J. Kolmerer, The Calendar Killer is set to be released on January 16, 2025, and will be available only on Amazon Prime Video. It is the screen adaptation of Sebastian Fitzek's ...